Ketorolac Tromethamine Injection
Hospira, Inc., a Pfizer Company · Unavailable · Reason: Other
Open FDA's page for this record- Update type
- Revised
- Initial posting date
- 03/26/2018
- Package NDC
- 0409-3795-01
- Generic name
- Ketorolac Tromethamine Injection
- Contact info
- 844-646-4398
- Availability
- Unavailable
- Related info
- Next Delivery and Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay
- Update date
- 10/21/2026
- Dosage form
- Injection
- Presentation
- Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0409-3795-01)
- Company name
- Hospira, Inc., a Pfizer Company
- Shortage reason
- Other
- Status
- Current
- Therapeutic category
- Analgesia/Addiction
- Harmonized identifiers (openFDA)
- Application number
- ANDA074802
- Brand name
- KETOROLAC TROMETHAMINE
- Generic name
- KETOROLAC TROMETHAMINE
- Manufacturer name
- Hospira, Inc.
- Product NDC
- 0409-3795, 0409-3793, 0409-3796
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- INTRAMUSCULAR, INTRAVENOUS
- Substance name
- KETOROLAC TROMETHAMINE
- RxCUI
- 860092, 1665459, 1665461
- SPL ID
- 4beb8ebd-934e-4181-8374-01be0bb80680
- SPL set ID
- 8accbb78-fc64-45d5-69b0-35c23a1d2a2e
- Package NDC
- 0409-3793-19, 0409-3793-01, 0409-3793-25, 0409-3795-19, 0409-3795-01, 0409-3795-25, 0409-3796-19, 0409-3796-01, 0409-3796-25
- UNII
- 4EVE5946BQ